(Q84296085)
Statements
Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours (English)
Ingrid M E Desar
H Jorn Bovenschen
Anja J N H Timmer-Bonte
Mireille V Cantarini
Winette T A Van Der Graaf
Michelle M Van Rossum
Carla M L Van Herpen